Followers | 157 |
Posts | 1232 |
Boards Moderated | 1 |
Alias Born | 03/06/2013 |
Tuesday, August 26, 2014 10:09:30 PM
M*CIGs #'s along with 99% of OTC company revs were horrible or non existant and it didn't break them.
Why is 2Mil your " make or break" number?
Anything over 1.025 mil will show growth.
What other factors can effect the Q3 bottom line?
Example: how many more B&M's will open? How many franchises ? How many free trials for direct marketing?
How much debt will be paid or refinanced ?
Their model is a high growth model that involves a large amount of proceeds reinvested into the comany's expanding footprint that should reap huge rewards done the road or yield a buyout.
My point is the history of revs is already best in class so why haven't the existing numbers "made" the pps instead of a constant battle.
This comes back to a non parasitic strong base of INVESTORS with a sustainable trading model, a comprehensive understanding of the compay's history and a clear vision of the future.
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM